You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

transplant ineligible

Showing 1 - 25 of 6,724
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-hodgkin Lymphoma Trial (Methotrexate, Rituximab (where available), Ibrutinib)

Not yet recruiting
  • Non-hodgkin Lymphoma
  • (no location specified)
Aug 11, 2023

Plasma Cell Leukemia Trial in Tianjin (anti-BCMA CAR-T, VRD-based regimen)

Recruiting
  • Plasma Cell Leukemia
  • anti-BCMA CAR-T
  • VRD-based regimen
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital Chinese Acad
Aug 4, 2023

Multiple Myeloma Trial in Tianjin (anti-BCMA CAR-T, VRD)

Recruiting
  • Multiple Myeloma
  • anti-BCMA CAR-T
  • VRD
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital Chinese Acad
May 5, 2023

Multiple Myeloma, Myeloma Multiple, Myeloma Trial in Poitiers (Drug and medical device)

Not yet recruiting
  • Multiple Myeloma
  • +2 more
  • Drug and medical device
  • Poitiers, France
    CHU Poitiers
Jun 1, 2023

Multiple Myeloma Trial in Rochester (Daratumumab, Lenalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Rochester, New York
    University of Rochester Medical Center
Jul 8, 2022

Multiple Myeloma Trial in Cologne (Daratumumab)

Recruiting
  • Multiple Myeloma
  • Cologne, Germany
    University of Cologne
Apr 4, 2022

Multiple Myeloma, Tumors, Tumor, Plasma Cell Trial (Belantamab Mafodotin-Blmf, Lenalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • +7 more
  • Belantamab Mafodotin-Blmf
  • +3 more
  • (no location specified)
Oct 11, 2022

Multiple Myeloma, Myeloma Trial in Poitiers (Isatuximab, Lenalidomide, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Myeloma
  • Poitiers, France
    CHU Poitiers
Sep 5, 2022

Multiple Myeloma Trial in Oslo, Stavanger, Trondheim (Isatuximab, bortezomib, lenalidomide, dexamethason)

Recruiting
  • Multiple Myeloma
  • Isatuximab, bortezomib, lenalidomide, dexamethason
  • Roskilde, Denmark
  • +3 more
Sep 20, 2022

Multiple Myeloma, Tumors, Tumors, Plasma Cell Trial (Belantamab Mafodotin-Blmf, Daratumumab, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • +7 more
  • Belantamab Mafodotin-Blmf
  • +3 more
  • (no location specified)
Mar 4, 2022

Multiple Myeloma Trial (Iberdomide, Bortezomib, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jul 18, 2022

Lenalidomide / Dexamethasone as First Line Therapy in Multiple

Active, not recruiting
  • Multiple Myeloma
    • Bochum, Germany
      Hämatologisch-Onkologische Schwerpunktpraxis
    Feb 1, 2022

    Myeloma, Multiple Trial in United States (Lenalidomide, Ixazomib, Daratumumab Injection)

    Recruiting
    • Myeloma, Multiple
    • Bangor, Maine
    • +7 more
    Mar 10, 2022

    Myeloma Multiple, Myeloma, Plasma-Cell, Myeloma-Multiple Trial in Israel (Carfilzomib, Daratumumab, Lenalidomide)

    Completed
    • Myeloma Multiple
    • +3 more
    • Afula, Israel
    • +13 more
    Jan 26, 2022

    Multiple Myeloma Trial in Worldwide (Elranatamab, Daratumumab, Lenalidomide)

    Recruiting
    • Multiple Myeloma
    • Nagaizumi-cho,Sunto-gun, Shizuoka, Japan
    • +7 more
    Jan 9, 2023

    Patient and Healthcare Provider Satisfaction of Daratumumab Use

    Recruiting
    • Multiple Myeloma
    • +5 more
    • Daratumumab
    • Frankfurt, Hessen, Germany
      Centrum für Hämatologie und Onkologie Bethanien
    Aug 1, 2022

    Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Jacksonville (Dexamethasone, Ibrutinib, Laboratory

    Suspended
    • Recurrent Plasma Cell Myeloma
    • Refractory Plasma Cell Myeloma
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Mar 22, 2022

    Mantle Cell Lymphoma Trial in Seoul (RB/RBAC alternating, RB)

    Not yet recruiting
    • Mantle Cell Lymphoma
    • RB/RBAC alternating
    • RB
    • Seoul, Gangnam-Gu, Korea, Republic of
      Samsung Medical Center
    Apr 18, 2022

    Multiple Myeloma Trial in Athens (Belantamab mafodotin)

    Recruiting
    • Multiple Myeloma
    • Belantamab mafodotin
    • Athens, Attica, Greece
      General Hospital of Athens "Alexandra"
    Mar 18, 2021

    Multiple Myeloma Trial in Denmark, Estonia, Norway (Selinexor 20 MG Oral Tablet, Bortezomib Injection, Lenalidomide capsule)

    Recruiting
    • Multiple Myeloma
    • Selinexor 20 MG Oral Tablet
    • +3 more
    • Aalborg, Denmark
    • +10 more
    Apr 22, 2022

    Lenalidomide in Combination With Dexamethasone in Clinical

    Active, not recruiting
    • Multiple Myeloma
      • Kirchdorf, Austria
      • +11 more
      May 16, 2022

      Mantle Cell Lymphoma Trial in United States (Ofatumumab (This arm is closed), Ofatumumab + Bendamustine)

      Active, not recruiting
      • Mantle Cell Lymphoma
      • Ofatumumab (This arm is closed)
      • Ofatumumab + Bendamustine
      • Basking Ridge, New Jersey
      • +5 more
      Oct 1, 2021

      Acute Myeloid Leukemia (AML), Cancer Trial in United States (venetoclax, azacytidine, decitabine)

      Completed
      • Acute Myeloid Leukemia (AML)
      • Cancer
      • Tempe, Arizona
      • +15 more
      Jun 10, 2022

      Multiple Myeloma, Myeloma Trial in Singapore (Daratumumab, Bortezomib, Dexamethasone)

      Recruiting
      • Multiple Myeloma
      • Myeloma
      • Singapore, Singapore
      • +1 more
      May 6, 2020

      Multiple Myeloma Trial in Austria, Germany (Carfilzomib, Thalidomide, Lenalidomide)

      Active, not recruiting
      • Multiple Myeloma
      • Graz, Austria
      • +20 more
      Jan 18, 2022